ES519991A0 - Procedimiento para la obtencion de compuestos derivados del acido 3-hidroxibutanoico. - Google Patents

Procedimiento para la obtencion de compuestos derivados del acido 3-hidroxibutanoico.

Info

Publication number
ES519991A0
ES519991A0 ES519991A ES519991A ES519991A0 ES 519991 A0 ES519991 A0 ES 519991A0 ES 519991 A ES519991 A ES 519991A ES 519991 A ES519991 A ES 519991A ES 519991 A0 ES519991 A0 ES 519991A0
Authority
ES
Spain
Prior art keywords
acid
hydroxibutanoic
procedure
compounds derived
obtaining compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES519991A
Other languages
English (en)
Spanish (es)
Other versions
ES8500240A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay SA
Original Assignee
Solvay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay SA filed Critical Solvay SA
Publication of ES8500240A1 publication Critical patent/ES8500240A1/es
Publication of ES519991A0 publication Critical patent/ES519991A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ES519991A 1982-02-23 1983-02-22 Procedimiento para la obtencion de compuestos derivados del acido 3-hidroxibutanoico. Granted ES519991A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8203100A FR2521857B1 (fr) 1982-02-23 1982-02-23 Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Publications (2)

Publication Number Publication Date
ES8500240A1 ES8500240A1 (es) 1984-10-01
ES519991A0 true ES519991A0 (es) 1984-10-01

Family

ID=9271331

Family Applications (2)

Application Number Title Priority Date Filing Date
ES519991A Granted ES519991A0 (es) 1982-02-23 1983-02-22 Procedimiento para la obtencion de compuestos derivados del acido 3-hidroxibutanoico.
ES532880A Granted ES532880A0 (es) 1982-02-23 1984-05-28 Un procedimiento para obtener composiciones farmaceuticas que contienen un derivado del acido 3-hidroxibutanoico y de una base inorganica u organica nitrogenada.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES532880A Granted ES532880A0 (es) 1982-02-23 1984-05-28 Un procedimiento para obtener composiciones farmaceuticas que contienen un derivado del acido 3-hidroxibutanoico y de una base inorganica u organica nitrogenada.

Country Status (21)

Country Link
US (2) US4579955A (cg-RX-API-DMAC7.html)
EP (1) EP0087192B1 (cg-RX-API-DMAC7.html)
JP (1) JPS58201746A (cg-RX-API-DMAC7.html)
KR (1) KR910000143B1 (cg-RX-API-DMAC7.html)
AT (1) ATE24478T1 (cg-RX-API-DMAC7.html)
AU (2) AU560757B2 (cg-RX-API-DMAC7.html)
CA (1) CA1203242A (cg-RX-API-DMAC7.html)
DE (1) DE3368601D1 (cg-RX-API-DMAC7.html)
DK (1) DK163235C (cg-RX-API-DMAC7.html)
ES (2) ES519991A0 (cg-RX-API-DMAC7.html)
FI (1) FI79523C (cg-RX-API-DMAC7.html)
FR (1) FR2521857B1 (cg-RX-API-DMAC7.html)
GR (1) GR77934B (cg-RX-API-DMAC7.html)
IE (1) IE54561B1 (cg-RX-API-DMAC7.html)
IL (1) IL67965A0 (cg-RX-API-DMAC7.html)
MX (1) MX156855A (cg-RX-API-DMAC7.html)
NO (1) NO161909C (cg-RX-API-DMAC7.html)
NZ (1) NZ203279A (cg-RX-API-DMAC7.html)
PH (1) PH21561A (cg-RX-API-DMAC7.html)
PT (1) PT76267A (cg-RX-API-DMAC7.html)
ZA (1) ZA831019B (cg-RX-API-DMAC7.html)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
USRE38604E1 (en) 1984-06-22 2004-09-28 Btg International Limited Fluid therapy with L-lactate and/or pyruvate anions
US6020007A (en) * 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
US4777288A (en) * 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
BE1001209A3 (fr) * 1987-11-19 1989-08-22 Solvay Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
US5292774A (en) * 1988-07-26 1994-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
DE4113984C2 (de) * 1991-04-29 2002-05-08 Koehler Chemie Dr Franz Salze der 4-Hydroxy-Buttersäure
ES2051222B1 (es) * 1992-03-12 1995-02-16 Sanmiguel Gabriel Serrano Procedimiento de neutralizacion de acido alfa-hidroxietanoico.
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
AU749638B2 (en) * 1997-03-17 2002-06-27 Btg International Limited Therapeutic compositions
US6613356B1 (en) 2000-10-10 2003-09-02 Victor Vlahakos Weight loss medication and method
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
US7947736B2 (en) * 2004-07-16 2011-05-24 Btg International Limited Oligomeric compounds
US7485743B2 (en) * 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
US20070225252A1 (en) * 2004-07-23 2007-09-27 Gross Richard A Ketogenic Saccharides
WO2006034361A2 (en) * 2004-09-21 2006-03-30 Ketocytonyx Inc. Dopaminergic mimetics
WO2006098767A2 (en) * 2004-09-21 2006-09-21 Ketocytonyx Inc. Treatment of adhd
RU2302239C1 (ru) * 2006-07-14 2007-07-10 Михаил Владимирович Покровский Способ фармакологической коррекции ишемии конечности
WO2008053982A1 (en) 2006-10-30 2008-05-08 Ophtecs Corporation Composition for treating allergy
ES2752030T3 (es) 2012-11-05 2020-04-02 Us Health Cuerpos cetónicos para proteger los tejidos del daño por radiación ionizante
WO2017086447A1 (ja) 2015-11-19 2017-05-26 協和発酵バイオ株式会社 ３－ヒドロキシイソ吉草酸の一価カチオン塩の結晶および該結晶の製造方法
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
JP6710098B2 (ja) * 2016-05-10 2020-06-17 大阪瓦斯株式会社 栄養剤組成物及び栄養補助食品
AU2017282515A1 (en) * 2016-06-24 2019-01-17 Otsuka Pharmaceutical Factory, Inc. Crystal of β-hydroxy β-methylbutyric acid amino acid salt and production method therefor
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
CN112341331B (zh) * 2019-08-07 2023-04-07 辽宁科硕营养科技股份有限公司 一种3-羟基丁酸盐及其制备方法与应用
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
WO2024192165A1 (en) * 2023-03-14 2024-09-19 The Board Of Trustees Of The Leland Stanford Junior University N-beta-hydroxybutyryl-amino acids and related compositions and methods
WO2025056246A1 (en) * 2023-09-11 2025-03-20 Societe Des Produits Nestle S.A. Polymorphs and compositions comprising same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2101097A (en) * 1934-07-26 1937-12-07 Wm S Merrell Co Products for rendering the urine bacteriostatic
US2799684A (en) * 1954-06-18 1957-07-16 Food Chemical And Res Lab Inc Crystalline compounds of tryptophane and methods of manufacturing them
NL279760A (cg-RX-API-DMAC7.html) * 1961-06-17
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
DE2733202A1 (de) * 1976-08-04 1978-02-09 Agroferm Ag Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4412943A (en) * 1981-02-23 1983-11-01 Kao Soap Co., Ltd. Liquid detergent composition
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Also Published As

Publication number Publication date
PH21561A (en) 1987-12-11
DK81583D0 (da) 1983-02-23
GR77934B (cg-RX-API-DMAC7.html) 1984-09-25
ES8506283A1 (es) 1985-07-01
FR2521857B1 (fr) 1985-10-31
DK81583A (da) 1983-08-24
ZA831019B (en) 1983-11-30
IE830366L (en) 1983-08-23
FI79523C (fi) 1990-01-10
FI830603L (fi) 1983-08-24
IL67965A0 (en) 1983-06-15
IE54561B1 (en) 1989-11-22
ATE24478T1 (de) 1987-01-15
AU560757B2 (en) 1987-04-16
FI79523B (fi) 1989-09-29
ES532880A0 (es) 1985-07-01
NO161909C (no) 1989-10-11
CA1203242A (fr) 1986-04-15
AU1162483A (en) 1983-09-01
US4579955A (en) 1986-04-01
EP0087192A1 (fr) 1983-08-31
JPS58201746A (ja) 1983-11-24
US4771074A (en) 1988-09-13
NO161909B (no) 1989-07-03
DE3368601D1 (en) 1987-02-05
KR840003414A (ko) 1984-09-08
AU6916187A (en) 1987-05-21
ES8500240A1 (es) 1984-10-01
DK163235B (da) 1992-02-10
FI830603A0 (fi) 1983-02-23
FR2521857A1 (fr) 1983-08-26
EP0087192B1 (fr) 1986-12-30
NZ203279A (en) 1985-04-30
PT76267A (fr) 1983-03-01
NO830618L (no) 1983-08-24
DK163235C (da) 1992-06-29
AU602329B2 (en) 1990-10-11
KR910000143B1 (ko) 1991-01-21
MX156855A (es) 1988-10-07

Similar Documents

Publication Publication Date Title
ES519991A0 (es) Procedimiento para la obtencion de compuestos derivados del acido 3-hidroxibutanoico.
ES536499A0 (es) Un procedimiento para la preparacion de nuevas 2-amino-5-hidroxi-4-metilpirimidinas.
DK165988C (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
ES2067589T3 (es) Derivados de amidas de aminoacidos.
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
DK0525123T3 (da) Antiatherosklerotiske og antithrombotiske 1-benzopyran-4-oner og 2-amino-1,3-benzoxazin-4-oner
PT83933B (pt) Processo para a preparacao de composicoes estaveis de activador do plasminogenio humano, tipo tecido
CY1105381T1 (el) Αλατα βορονικου οξεως
ES8403493A1 (es) Procedimiento para la preparacion de proteinas succiniladas que contienen hierro.
DK0489877T3 (da) Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
AT365926B (de) Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen
DK527186D0 (da) Bronchodilaterende farmaceutisk praeparat
ES2037003T3 (es) Procedimiento para preparar peptidos empleando percloratos.
ES536967A0 (es) Procedimiento para la preparacion de un derivado de n-(4-acetilaminofenacil)-amina
ES2014041A6 (es) Un procedimiento para preparar un derivado de amina.
DK222886A (da) Propionylanilider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303